Patrick Campbell

Discussing how a recently approved label update for sodium zirconium cyclosilicate impacts the treatment armamentarium of clinicians.

Social isolation could increase risk for cardiovascular events by 40%, according to new research presented at EAN 2020 Virtual Congress.

A new analysis of 12 randomized clinical trials is shedding more definitive light on the impact of antihypertensive agents on risk of dementia and cognitive decline.

Young Kim, PhD, discusses the use of a smartphone app that helps clinicians assess patients for anemia.

New research suggests combining agents from the 3 classes could pay major dividends in terms of event-free and overall survival.

New data presented at EAN 2020 Congress dives into the impact of sleep-wake disturbances on recurrent stroke events.

The approval of Phexxi makes it the first non-hormonal prescription gel for the prevention of pregnancy.

The move comes less than 3 months after a United States District Court for the District of Nevada invalidated 6 Vascepa patients owned by Amarin.

The Chiesi Group announced the approval in a statement on May 21.

A new analysis of the DASH trial found a fruit-and-vegetable diet was associated with lower levels of hs-cTnl and NT-proBNP.

New data from NYU Langone Health found the rate of stroke in hospitalized patients was less than 1%, much lower than the reported rate of 2-5% from other countries.

New data found an 18-year-old female patient developed subacute thyroiditis following a COVID-19 infection.

New research suggests BP during and after exercise could indicate increased risk of hypertension, cardiovascular disease, and mortality.

A new meta-analysis finds women are less likely to receive ACE inhibitors, statins, and other recommended CV medications than their male counterparts.

Discussing tips and strategies for effectively taking medical practices, especially those focused on obesity management, virtual.

Discussing the combined and respective roles of nutrition and pharmacological agents in the management of obesity.

New research from an analysis of the Rush MAP is examining associations between FGCRS and cognitive decline later in life.

A new analysis from SCAI 2020 is shedding light on the use of the Melody TPV in patients who underwent valve implantation within an existing dysfunctional right ventricular outflow tract conduit or bioprosthetic pulmonary valve.

A new analysis of 28 studies including more than 90k patients suggests 1-in-10 of these conditions is misdiagnosed, results in delays in treatment and potential harm.

Data presented at SCAI 2020 examining a novel cell therapy suggests it could help reduce angina in patients with non-obstructive coronary artery disease.

An analysis of the TWILIGHT trial presented at SCAI examines SYNERGY BP-EES in a high-risk patient population.

Results of the latest REDUCE-IT analysis shed light on the degree to which icosapent ethyl can reduce revascularization.

New research suggests the presence of either condition can wreak havoc on an older adult's ability for movement, self-care, and household activities.

New research has found use of medication alone was noninferior to using medication and graduated compression socks for preventing VTE following non-emergency surgery.

New research suggests there may be a link between elevated fasting blood glucose levels and cognitive decline after a stroke.

New research suggests consuming just one sugar-sweetened beverage per day increases risk of CVD by nearly 20% in women.

New research suggests a residual shunt following PFO closure puts patients at a much greater risk of recurrent stroke or TIA.

A new AI model from the New York Eye and Ear Infirmary of Mount Sinai boasts 99.2% accuracy for diagnosing intermediate or late AMD.

A new research letter has found declines in rural areas have not been as pronounced as declines in metropolitan areas.

New research suggests a group of 6 cancer biomarkers was associated with all-cause mortality and HF hospitalizations.